Fox Run Management’s Nuvalent NUVL Stock Holding History

Fox Run Management’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,173	Closed	-$790K	–	1192
2026 Q1	$790K	Buy	+8,173	New	+$833K	0.14%	251

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Fox Run Management's NUVL Position: Q2 2026 in Review

Fox Run Management sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 8,173 shares — an estimated $790K sold.

Fox Run Management first reported a position in NUVL in Q1 2026 and held it in 1 quarter. The position peaked at $790K in Q1 2026. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Fox Run Management reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
Fox Run Management sold 8,173 Nuvalent shares in Q2 2026, an estimated $790K.
Fox Run Management first reported a position in Nuvalent in Q1 2026 and held it in 1 quarter.
Fox Run Management's Nuvalent position peaked at $790K in Q1 2026.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.